Kemppainen Venla, Mentula Maarit, Palkama Vilja, Heikinheimo Oskari
The Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University hospital, Helsinki, Finland.
The Department of Anesthesiology and Intensive Care Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Contraception. 2022 Nov;115:6-11. doi: 10.1016/j.contraception.2022.07.001. Epub 2022 Jul 21.
To compare oxycodone administration via intravenous patient-controlled analgesia (IVPCA) vs on-demand administration during late-first- and second-trimester medically induced abortion.
A prospective randomized controlled study. We enrolled women between 64 to 128 days of gestation in the study between June 2016 and August 2018. Participants were randomized to receive oxycodone either via IVPCA or given on-demand orally, intramuscularly, or intravenously. Pain intensity and satisfaction with care were measured using the visual analogue scale (VAS, 0-100mm).
Altogether 99 participants were randomized: 48 in IVPCA group and 51 in on-demand group. Median gestational age was similar between groups (74 days [Interquartile range, IQR 69-81] in the IVPCA group vs 72 [69-80] in the control group, p = 0.587). Peak maximal pain was severe in both groups (median pain VAS was 62 [IQR 44-84] and 71 [IQR 56-90], p = 0.52). The odds for severe pain (highest pain VAS≥70) were similar between the groups (IVPCA group OR 0.51 [95% Confidence Interval 0.22-1.18], p = 0.118). In contrast, the odds for mild or tolerable pain (highest pain VAS≤40) were higher in the IVPCA group (OR 4.06 [95% CI 1.05-16.04], p = 0.043). Nevertheless, satisfaction with care was high (VAS 94 [89-100]) in both groups. Of those experiencing severe pain, 94.0% declared pain medication as adequate.
Women often experience severe pain during medical abortion irrespective of the mode of opiate administration. Oxycodone administration via IVPCA permits women to self-administer analgesics when experiencing pain, raising the odds for mild or tolerable pain during abortion care. Satisfaction with care was high.
Medical abortion in late-first- and second-trimester is often painful experience. IVPCA offers a good method of choice for analgesia and raises the odds for tolerable pain (pain VAS less than 40) experience when compared to on-demand administration of analgesics.
比较在孕早期和孕中期药物流产后期通过静脉自控镇痛(IVPCA)给予羟考酮与按需给药的效果。
一项前瞻性随机对照研究。我们在2016年6月至2018年8月期间招募了妊娠64至128天的女性参与研究。参与者被随机分为通过IVPCA接受羟考酮治疗组或按需口服、肌肉注射或静脉注射给药组。使用视觉模拟量表(VAS,0 - 100mm)测量疼痛强度和护理满意度。
共99名参与者被随机分组:IVPCA组48名,按需给药组51名。两组的中位孕周相似(IVPCA组为74天[四分位间距,IQR 69 - 81],对照组为72天[69 - 80],p = 0.587)。两组的最大疼痛峰值均较严重(疼痛VAS中位数分别为62[IQR 44 - 84]和71[IQR 56 - 90],p = 0.52)。两组中严重疼痛(最高疼痛VAS≥70)的几率相似(IVPCA组比值比OR 0.51[95%置信区间0.22 - 1.18],p = 0.118)。相比之下,IVPCA组中轻度或可耐受疼痛(最高疼痛VAS≤40)的几率更高(OR 4.06[95%CI 1.05 - 16.04],p = 0.043)。然而,两组的护理满意度都很高(VAS为94[89 - 100])。在经历严重疼痛的患者中,94.0%表示止痛药物足够。
无论阿片类药物的给药方式如何,女性在药物流产期间通常都会经历严重疼痛。通过IVPCA给予羟考酮可使女性在疼痛时自行给药,增加了流产护理期间出现轻度或可耐受疼痛的几率。护理满意度很高。
孕早期和孕中期的药物流产通常是痛苦的经历。与按需给予镇痛药相比,IVPCA提供了一种良好的镇痛选择方法,并增加了出现可耐受疼痛(疼痛VAS小于40)的几率。